(Q37379594)

20 August 2017

Importance of dose timing to achieving undetectable viral loads (English)

1 reference

20 August 2017

1 reference

3

0 references

Ira B. Wilson

8

0 references

Mary Bachman DeSilva

object named as

Mary Bachman Desilva

9

0 references

Christopher J Gill

object named as

Christopher J Gill

1

0 references

Lora Sabin

2

object named as

Lora L Sabin

1 reference

20 August 2017

Xu Keyi

4

1 reference

20 August 2017

Zhang Jianbo

5

1 reference

20 August 2017

Tao Li

6

1 reference

20 August 2017

Wan-Ju Wu

7

1 reference

20 August 2017

8 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

14

1 reference

20 August 2017

4

1 reference

20 August 2017

785-793

1 reference

https://scigraph.springernature.com/pub.10.1007/s10461-009-9555-9

20 August 2017

0 references

cites work

Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Compliance with tricyclic antidepressants: the value of four different methods of assessment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Optimal recall period and response task for self-reported HIV medication adherence

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

A comparison study of multiple measures of adherence to HIV protease inhibitors.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

The natural history of medication compliance in a drug trial: limitations of pill counts

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3857692

Patterns of adherence with antiretroviral medications: an examination of between-medication differences

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19353263

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19353263

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19353263

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10461-009-9555-9

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

19353263

1 reference